FEPAXIM Trademark

Trademark Overview

On Thursday, March 1, 2012, a trademark application was filed for FEPAXIM with the United States Patent and Trademark Office. The USPTO has given the FEPAXIM trademark a serial number of 79114481. The federal status of this trademark filing is IR CANCELLED - US REGISTRATION CANCELLED as of Tuesday, March 1, 2022. This trademark is owned by NOVARTIS AG. The FEPAXIM trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the prevention or treatment of diseases and disorders of the nervous system, the immune system, the cardiovascular and metabolic system including diabetes, the respiratory system, musculoskeletal and inflammatory disorders, or for use in dermatology, oncology, hematology, ophthalmology, in transplantation; pharmaceutical preparations for use in gastroenterology, for the prevention and treatment of ocular disorders; anti-infective, antibiotic, antiviral and anti-fungal preparations; antibacterial pharmaceuticals; vaccines; diagnostic preparations for medical use
fepaxim

General Information

Serial Number79114481
Word MarkFEPAXIM
Filing DateThursday, March 1, 2012
Status404 - IR CANCELLED - US REGISTRATION CANCELLED
Status DateTuesday, March 1, 2022
Registration Number4284496
Registration DateTuesday, February 5, 2013
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, November 20, 2012

Trademark Statements

Goods and ServicesPharmaceutical preparations for the prevention or treatment of diseases and disorders of the nervous system, the immune system, the cardiovascular and metabolic system including diabetes, the respiratory system, musculoskeletal and inflammatory disorders, or for use in dermatology, oncology, hematology, ophthalmology, in transplantation; pharmaceutical preparations for use in gastroenterology, for the prevention and treatment of ocular disorders; anti-infective, antibiotic, antiviral and anti-fungal preparations; antibacterial pharmaceuticals; vaccines; diagnostic preparations for medical use

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status CodeF - NOT AVAILABLE
Class Status DateFriday, September 6, 2019
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameNovartis AG
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressCH
Party NameNOVARTIS AG
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressCH
Party NameNOVARTIS AG
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCH

Trademark Events

Event DateEvent Description
Sunday, September 25, 2022NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED
Sunday, September 25, 2022DEATH OF INTERNATIONAL REGISTRATION
Friday, July 10, 2020TOTAL INVALIDATION PROCESSED BY THE IB
Friday, June 12, 2020TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Friday, June 12, 2020INVALIDATION PROCESSED
Wednesday, May 6, 2020TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Friday, September 6, 2019CANCELLED SECTION 71
Monday, February 5, 2018COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Friday, September 6, 2013FINAL DECISION TRANSACTION PROCESSED BY IB
Wednesday, August 7, 2013FINAL DISPOSITION NOTICE SENT TO IB
Wednesday, August 7, 2013FINAL DISPOSITION PROCESSED
Sunday, May 5, 2013FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Saturday, April 13, 2013NEW REPRESENTATIVE AT IB RECEIVED
Saturday, February 23, 2013CHANGE OF NAME/ADDRESS REC'D FROM IB
Tuesday, February 5, 2013REGISTERED-PRINCIPAL REGISTER
Monday, November 26, 2012NOTIFICATION PROCESSED BY IB
Tuesday, November 20, 2012OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, November 20, 2012PUBLISHED FOR OPPOSITION
Wednesday, October 31, 2012NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, October 31, 2012NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, October 31, 2012NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, October 15, 2012LAW OFFICE PUBLICATION REVIEW COMPLETED
Monday, October 15, 2012ASSIGNED TO LIE
Monday, October 1, 2012APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, September 18, 2012TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, September 18, 2012CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, September 18, 2012TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, August 27, 2012ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, August 27, 2012TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Saturday, August 11, 2012REFUSAL PROCESSED BY IB
Friday, July 27, 2012APPLICATION FILING RECEIPT MAILED
Tuesday, July 24, 2012NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Tuesday, July 24, 2012REFUSAL PROCESSED BY MPU
Tuesday, July 24, 2012NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Monday, July 23, 2012NON-FINAL ACTION WRITTEN
Monday, July 23, 2012ASSIGNED TO EXAMINER
Monday, July 23, 2012NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Friday, July 20, 2012LIMITATION FROM ORIGINAL APPLICATION ENTERED
Thursday, July 19, 2012SN ASSIGNED FOR SECT 66A APPL FROM IB

Related Keywords

fepaxim preparations system disorders pharmaceutical anti treatment prevention antibiotic infective gastroenterology